"Repurposing of Heterocyclic Compounds as Anti- COVID-19 (SARS-Cov-2) Therapeutics: A Review"

Abstract

The ongoing outbreak of the existing and mutated strains of coronavirus has been a cause of great concern worldwide. It has posed critical challenges for medical researchers and public health. Though a staggering number of vaccines have been developed, few of which are still under various phases of clinical trials, the development strategy for the COVID-19 therapy is the need of the hour. Heterocyclic moieties are pivotal in the field of medicine. This review covers the different classes of pre-existing drugs constituting various heterocyclic analogs that have been repurposed for the possible treatment of the COVID-19 disease. Moreover, it can also help the pharmaceutical industry to develop a new class of advanced medicine to fight against Covid-19.